Patrick Soon-Shiong, doctor and entrepreneur, has been hard at work building his NantWorks health empire. The company aims to connect all of a patient's health data and leverage it with genetic information to revolutionize the healthcare experience. Investors have been drawn to the gambit: In July 2015 healthcare software firm Allscripts Healthcare Solutions invested $200 million into NantHealth, one of ten Nant subsidiaries, valuing it at $2 billion. Soon-Shiong took NantKwest, a cancer drugmaker, public in July, raising $200 million; he owns more than 50% of the company. The son of Chinese immigrants to South Africa, Soon-Shiong graduated from high school at age 16 and became a doctor at 23. After making a name for himself as a surgeon, he founded two drug companies in the U.S., Abraxis and American Pharmaceutical Partners, which he sold for a combined $9.1 billion between 2008 and 2010. He invented a cancer drug, Abraxane, which, after years of slow sales, is now a blockbuster thanks to its efficacy against pancreatic cancer. A member of the Buffett-Gates Giving Pledge, Soon-Shiong plans to give away at least half his fortune. He has donated $136 million to St. John's Health Center in Santa Monica, Calif. He owns a 4% stake in the Los Angeles Lakers basketball team.